Clèries Ramon, Ameijide Alberto, Buxó Maria, Vilardell Mireia, Martínez José Miguel, Alarcón Francisco, Cordero David, Díez-Villanueva Ana, Yasui Yutaka, Marcos-Gragera Rafael, Vilardell Maria Loreto, Carulla Marià, Galceran Jaume, Izquierdo Ángel, Moreno Víctor, Borràs Josep M
Pla Director d'Oncología, IDIBELL, Hospitalet de Llobregat, Barcelona, España; Department de Ciències Clíniques, Universitat de Barcelona, Barcelona, España.
Registre de Càncer de Tarragona, Fundació per la Prevenció del Càncer (FUNCA), IISPV, Reus, Tarragona, España.
Gac Sanit. 2018 Sep-Oct;32(5):492-495. doi: 10.1016/j.gaceta.2017.10.015. Epub 2018 Jan 19.
Relative survival has been used as a measure of the temporal evolution of the excess risk of death of a cohort of patients diagnosed with cancer, taking into account the mortality of a reference population. Once the excess risk of death has been estimated, three probabilities can be computed at time T: 1) the crude probability of death associated with the cause of initial diagnosis (disease under study), 2) the crude probability of death associated with other causes, and 3) the probability of absolute survival in the cohort at time T. This paper presents the WebSurvCa application (https://shiny.snpstats.net/WebSurvCa/), whereby hospital-based and population-based cancer registries and registries of other diseases can estimate such probabilities in their cohorts by selecting the mortality of the relevant region (reference population).
相对生存率已被用作衡量一组癌症确诊患者额外死亡风险随时间演变的指标,同时考虑到参照人群的死亡率。一旦估算出额外死亡风险,就可以在时间T计算出三个概率:1)与初始诊断病因(所研究疾病)相关的粗死亡率,2)与其他病因相关的粗死亡率,3)该队列在时间T的绝对生存概率。本文介绍了WebSurvCa应用程序(https://shiny.snpstats.net/WebSurvCa/),通过该程序,基于医院和基于人群的癌症登记处以及其他疾病登记处可以通过选择相关地区(参照人群)的死亡率来估算其队列中的此类概率。